The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786
Clofibrate and Niacin in Coronary Heart Disease
(1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03240160024021 · Cited by 1,747
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410050061031 · Cited by 957
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Identification of a new class of steroid hormone receptors
Giguère, V., Yang, N., Segui, P., & Evans, R. M. (1988) · Nature · doi:10.1038/331091a0 · Cited by 867
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
Orphan Nuclear Receptors: From Gene to Function*
Giguère, V. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0378 · Cited by 855
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000111245.75752.c6 · Cited by 718
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697
Carlson, L. A., & ROSENHAMER, G. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15891.x · Cited by 677
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599
Sher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
Delerive, P., Martin-Nizard, F., Chinetti, G., Trottein, F., Fruchart, J.-C., Najib, J., Duriez, P., & Staels, B. (1999) · Circulation Research · doi:10.1161/01.res.85.5.394 · Cited by 502
Schmidt, A. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1634 · Cited by 477
Ericsson, C.-G., de Faire, U., Grip, L., Svane, B., Hamsten, A., & Nilsson, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91343-4 · Cited by 426
&NA; (1996) · The Endocrinologist · doi:10.1097/00019616-199609000-00019 · Cited by 417
Staels, B., Vu-Dac, N., Kosykh, V. A., Saladin, R., Fruchart, J. C., Dallongeville, J., & Auwerx, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117717 · Cited by 410
Greene, M. E., Blumberg, B., McBride, O. W., Yi, H., Kronquist, K. E., Kwan, K. W., Hsieh, L., Greene, G. L., & Nimer, S. D. (1995) · Europe PMC (PubMed Central) · Cited by 399
Vu-Dac, N., Schoonjans, K., Kosykh, V, Dallongeville, J., Fruchart, J. C., Staels, B., & Auwerx, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118118 · Cited by 397
Chiang, J. Y. L., Kimmel, R., & Stroup, D. (2001) · Gene · doi:10.1016/s0378-1119(00)00518-7 · Cited by 375
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate.
Miettinen, M., Turpeinen, O., & Karvonen, M. J. (1979) · Heart · doi:10.1136/hrt.42.3.370 · Cited by 360
IJpenberg, A., Jeannin, E., Wahli, W., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20108 · Cited by 352
Lemberger, T., Saladin, R., Vázquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., & Auwerx, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1764 · Cited by 329
Mascaró, C., Acosta, E., Ortiz, J. A., Marrero, P. F., Hegardt, F. G., & Haro, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8560 · Cited by 318 · cited 1×
“Furthermore, the enzyme carnitine palmitoyl transferase I (CPTI) is up regulated by PPAR- through a functional PPRE in the promoter region of the gene (35).”
BackgroundVu-Dac, N., Chopin-Delannoy, S., Gervois, P., Bonnelye, E., Martin, G., Fruchart, J.-C., Laudet, V., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25713 · Cited by 297
Gonzalez, F. J., Peters, J. M., & Cattley, R. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.22.1702 · Cited by 290
Maglich, J. M., Sluder, A., Guan, X., Shi, Y., McKee, D. D., Carrick, K., Kamdar, K., Willson, T. M., & Moore, J. T. (2001) · Genome Biology · doi:10.1186/gb-2001-2-8-research0029 · Cited by 266
How many nuclear hormone receptors are there in the human genome?
Robinson-Rechavi, M., Carpentier, A.-S., Duffraisse, M., & Laudet, V. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02417-9 · Cited by 242
Ischaemic Heart Disease: A Secondary Prevention Trial Using Clofibrate
Research Committee of the Scottish Society of Physicians (1971) · BMJ · doi:10.1136/bmj.4.5790.775 · Cited by 242
Post, S. M., Duez, H., Gervois, P. P., Staels, B., Kuipers, F., & Princen, H. M. G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098228 · Cited by 217
Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice
Torra, I. P., Chinetti, G., Duval, C., Fruchart, J.-C., & Staels, B. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00002 · Cited by 210
Inoue, I., Shino, K., Noji, S., Awata, T., & Katayama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8622 · Cited by 199
Cross-Talk between Fatty Acid and Cholesterol Metabolism Mediated by Liver X Receptor-
Tobin, K. A. R. (2000) · Molecular Endocrinology · doi:10.1210/me.14.5.741 · Cited by 195
PPARα Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages
Neve, B. P., Corseaux, D., Chinetti, G., Zawadzki, C., Fruchart, J.-C., Duriez, P., Staels, B., & Jude, B. (2001) · Circulation · doi:10.1161/01.cir.103.2.207 · Cited by 191
Tenkanen, L., Mänttäri, M., & Manninen, V. (1995) · Circulation · doi:10.1161/01.cir.92.7.1779 · Cited by 188
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin
Shalev, A. (1996) · Endocrinology · doi:10.1210/en.137.10.4499 · Cited by 187
Juge-Aubry, C. E., Hammar, E., Siegrist-Kaiser, C., Pernin, A., Takeshita, A., Chin, W. W., Burger, A. G., & Meier, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10505 · Cited by 179
Vohl, M.-C., Lepage, P., Gaudet, D., Brewer, C. G., Bétard, C., Perron, P., Houde, G., Cellier, C., Faith, J. M., Després, J.-P., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32037-x · Cited by 176
PPARα Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes
Marx, N., Mackman, N., Schönbeck, U., Yilmaz, N., Hombach, V., Libby, P., & Plutzky, J. (2001) · Circulation · doi:10.1161/01.cir.103.2.213 · Cited by 175
Flavell, D. M., Torra, I. P., Jamshidi, Y., Evans, D., Diamond, J. R., Elkeles, R. S., Bujac, S. R., Miller, G., Talmud, P. J., Staels, B., et al. (2000) · Diabetologia · doi:10.1007/s001250051357 · Cited by 171
Jonkers, I. J., Mohrschladt, M. F., Westendorp, R. G., van der Laarse, A., & Smelt, A. H. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01123-8 · Cited by 166
Flavell, D. M., Jamshidi, Y., Hawe, E., Pineda‐Torra, I., Taskinen, M., Frick, M. H., Nieminen, M. S., Kesäniemi, Y. A., Pasternack, A. I., Staels, B., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012145.80593.25 · Cited by 149
Heller, F., & Harvengt, C. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544015 · Cited by 147
Lalwani, N. D., Reddy, M. K., Qureshi, S. A., et al. (1983) · Human Toxicology · doi:10.1177/096032718300200103 · Cited by 136
Tai, E. S., Demissie, S., Cupples, L. A., Corella, D., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012302.11991.42 · Cited by 136
Sapone, A., Peters, J. M., Sakai, S., Tomita, S., Papiha, S. S., Dai, R., Friedman, F. K., & Gonzalez, F. J. (2000) · Pharmacogenetics · doi:10.1097/00008571-200006000-00006 · Cited by 135
Hertz, R., Berman, I., KEPPLER, D. O. R., & Bar‐Tana, J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00242.x · Cited by 104
Bouly, M., Masson, D., Gross, B. S., Jiang, X., Fiévet, C., Castro, G. R., Tall, A. R., Fruchart, J., Staels, B., Lagrost, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101160200 · Cited by 99
Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease.
Lacquemant, C., Leprêtre, F., Pineda‐Torra, I., Manraj, M., Charpentier, G., Ruiz, J. C., Staels, B., & Froguel, P. (2000) · PubMed · Cited by 90
Cheema, S. K., & Agellon, L. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12530 · Cited by 85
Brisson, D., Ledoux, K., Bossé, Y., St‐Pierre, J., Julien, P., Perron, P., Hudson, T. J., Vohl, M., & Gaudet, D. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00007 · Cited by 74
Syvänne, M., Nieminen, M. S., Frick, M. H., Kauma, H., Majahalme, S. K., Virtanen, V., Kesäniemi, Y. A., Pasternack, A. I., Ehnholm, C., & Taskinen, M. (1998) · Circulation · doi:10.1161/01.cir.98.19.1993 · Cited by 70
Ståhlberg, D., Reihnér, E., Rudling, M. J., Berglund, L., Einarsson, K., & Angelin, B. (1995) · Hepatology · doi:10.1002/hep.1840210421 · Cited by 67
Evans, D., Aberle, J., Wendt, D., Wolf, A. M., Beisiegel†, U., & Mann, W. A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100189 · Cited by 65
Bisgaier, C. L., Essenburg, A. D., Barnett, B. C., Auerbach, B. J., Haubenwallner, S., Leff, T., White, A. D., Creger, P. L., Pape, M. E., Rea, T. J., et al. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34199-7 · Cited by 58
A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients
Lemieux, I., Laperrière, L., Džavík, V., Tremblay, G., Bourgeois, J., & Després, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00711-0 · Cited by 56
Effects of ciprofibrate on LDL metabolism in man
Gaw, A., Packard, C. J., CASLAKE, M. J., Griffin, B. A., Lindsay, G. M., Thomson, J., Vallance, B. D., Wosornu, D., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90108-2 · Cited by 48
Bossé, Y., Pascot, A., Dumont, M., Brochu, M., Prud’homme, D., Bergeron, J., Després, J., & Vohl, M. (2002) · Genetics in Medicine · doi:10.1097/00125817-200207000-00010 · Cited by 38
Yoshida, H., Ishikawa, T., Ayaori, M., Shige, H., Ito, T., Suzukawa, M., & Nakamura, H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00062-8 · Cited by 34
Jamshidi, Y., Flavell, D. M., Hawe, E., MacCallum, P. K., Meade, T. W., & Humphries, S. E. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00002-3 · Cited by 24
SAITOH, K., Mori, T., Kasai, H., NAGAYAMA, T., Tsuchiya, A., & Ohbayashi, S. (1995) · Folia Pharmacologica Japonica · doi:10.1254/fpj.106.41 · Cited by 23
Puckey, L., & Knight, B. L. (2001) · Pharmacogenetics · doi:10.1097/00008571-200110000-00008 · Cited by 9
Cited by
PGC-1α: a key regulator of energy metabolism
Liang, H., & Ward, W. F. (2006) · Advances in Physiology Education · doi:10.1152/advan.00052.2006 · Cited by 1,245
Duell, P. B., Welty, F. K., Miller, M., Chait, A., Hammond, G., Ahmad, Z., Cohen, D. E., Horton, J. D., Pressman, G. S., Toth, P. P., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000153 · Cited by 727
Van Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02067.x · Cited by 439
Self-citationMeta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression
Sublette, M. E., Ellis, S. P., Geant, A. L., & Mann, J. J. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06634 · Cited by 417
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Metadata
- Authors
- van Raalte, D. H., Li, M., Pritchard, P. H., & Wasan, K. M.
- Venue
- Pharmaceutical Research
- Published
- 2004-09
- Volume
- 21
- Issue
- 9
- Pages
- 1531-1538
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1965546738
- Cited by
- 269
- References
- 92
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.